Unravelling the ties that bind: The intersection of obesity, osteoarthritis, and inflammatory pathways with emphasis on glucagon-like peptide-1 agonists.
解開相互關聯的紐帶:肥胖、骨關節炎與炎症途徑的交集,重點在於glucagon-like peptide-1 agonists。
Clin Obes 2024-08-17
Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort.
糖尿病樣肽-1受體激動劑作為透過體重減輕介入膝關節骨關節炎的疾病修飾療法:上海骨關節炎群的研究發現。
Ann Rheum Dis 2023-09-19
Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis.
肥胖時我們的生物學反對我們:對骨關節炎管理影響的敘事性回顧。
Osteoarthr Cartil Open 2023-09-26
Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity.
肥胖患者中胰高血糖素樣肽-1受體激動劑對骨骼健康影響的敘述性回顧。
Calcif Tissue Int 2024-03-08
Five-year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists.
病患處方葡萄糖樣肽-1(GLP-1)受體激動劑後,進展至骨關節炎及全關節置換術的五年發病率。
J Arthroplasty 2024-06-10
Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon.
用於醫療監督下減重的 Glucagon-Like Peptide Receptor-1 促效劑在髖關節和膝關節骨關節炎患者中的應用:關節置換外科醫生的關鍵考量。
Arthroplast Today 2024-07-29
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions.
糖尿病與骨關節炎:探討胰島素、Metformin 及 GLP-1 基礎介入的相互作用與治療意涵。
Biomedicines 2024-08-29